Ontology highlight
ABSTRACT: Aims/hypothesis
Type 1 diabetes is an autoimmune disorder that is characterised by destruction of pancreatic beta cells by autoreactive T lymphocytes. Although islet autoantibodies (AAb) are an indicator of disease progression, specific immune biomarkers that can be used as target molecules to halt development of type 1 diabetes have not been discovered. Soluble immune checkpoint molecules (sICM) play a pivotal role in counteracting excessive lymphocyte responses, but their role in type 1 diabetes is unexplored. In this longitudinal study, we measured sICM levels in AAb-positive (AAb+) children to identify molecules related to type 1 diabetes progression.Methods
We measured the levels of 14 sICM in the sera of AAb+ children (n=57) compared to those wit
SUBMITTER: Bruzzaniti S
PROVIDER: S-EPMC10904438 | biostudies-literature | 2024 Apr
REPOSITORIES: biostudies-literature